Starling Oncology, Inc. Accounts Payable
Starling Oncology, Inc. (STLN) had Accounts Payable of $60.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $60.28M.
- 2026-03-31: Accounts Payable, Current $47.65M.
- 2025-12-31: Accounts Payable, Current $43.17M.
- 2025-09-30: Accounts Payable, Current $35.63M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $60.28M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $47.65M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $43.17M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $35.63M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $34.93M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $29.29M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $24.32M 10-K · filed 2026-03-12 |
| 2024-09-30 | $24.57M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $15.75M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $21.02M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $14.43M 10-K · filed 2025-03-26 |
| 2023-09-30 | $13.33M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $13.12M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $11.95M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $9.37M 10-K · filed 2024-03-28 |
| 2022-09-30 | $11.15M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $13.90M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $12.60M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $15.56M 10-K · filed 2023-03-16 |
| 2021-09-30 | $961.08K 10-Q/A · filed 2021-12-14 |
| 2021-06-30 | $961.66K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $24.71K 10-Q · filed 2021-05-28 |
| 2020-12-31 | $12.64M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.33K 10-Q · filed 2020-11-13 |
| 2020-03-31 | $288.26K 10-Q · filed 2020-05-08 |